ciltacabtagene autoleucel
Janssen
['cartitude-2', 'cilta-cel', 'cartitude']
encouraging news for mm pts with early relapse within 12 months of initial therapy and refractory to imid and pi. cartitude-2 cohort b investigating cilta-cel shows pfs and os of 83% after 18 months #eha2023 
Myeloma Canada is a registered non-profit organization created by, and for, people living with myeloma. We have been Making Myeloma Matter since 2005.